MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Low-frequency repetitive transcranial cerebellar magnetic stimulation as an ‘add-on’ therapy in patients with Essential Tremor

H.-W. Shin, M. Hallett, Y. Sohn (Bethesda, MD, USA)

Meeting: 2017 International Congress

Abstract Number: 765

Keywords: Essential tremor(ET), Repetitive transcranial magnetic stimulation(rTMS)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Tremor

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To investigate effect of cerebellar low-frequency repetitive transcranial magnetic stimulation (rTMS) as an ‘add-on’ treatment on patients with Essential tremor (ET)

Background: ET is a most common movement disorder in adult. It is not life threatening, but it can significantly impair the patients’ activity of daily lives. Beta-blockers and primidone have been used as the treatment of choices for patients with ET. However, up to 50% of the ET patients report that they are not satisfied to improve tremor symptoms by the medications.

Methods: This is a single-center, prospective, sham-controlled and single-blinded study. Fourteen ET patients participated in this study. ET was diagnosed when the patient has bilateral postural or kinetic tremor on the arms, no dystonia and no possibility of drug-induced secondary tremor. In addition, we included the subject in this study only if the patient has significant tremor with beta-blockers and other additive drugs as the symptomatic management. Subjects were randomized as a group of receiving real-rTMS and another group of receiving sham-rTMS. rTMS was applied over each cerebellum in turn. The order of the stimulation to each cerebellum was randomly assigned. For 5 days, 600 stimulations a day were applied with an intensity of 90% of the resting motor threshold (RMT) with 1-Hz frequency. Clinical tremor rating scale (CTRS) was measured before, a week and 5 weeks after starting day of rTMS procedure. 

Results: Eight and 6 patients were randomized as groups of real and sham-rTMS, respectively (Figure 1). The mean age, symptoms duration and baseline CTRS scores were comparable between two groups (Table 1). ANOVA analysis showed that all three parts (A, B and C) of CTRS were not different before, a week and 5 weeks after starting rTMS procedure both in real and sham-rTMS groups (Figure 2). There was no adverse event including headache, dizziness, syncope and seizure in all subjects.

Conclusions: Cerebellar low-frequency rTMS is safe but not effective as an ‘add-on’ therapy in patients with ET.

To cite this abstract in AMA style:

H.-W. Shin, M. Hallett, Y. Sohn. Low-frequency repetitive transcranial cerebellar magnetic stimulation as an ‘add-on’ therapy in patients with Essential Tremor [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/low-frequency-repetitive-transcranial-cerebellar-magnetic-stimulation-as-an-add-on-therapy-in-patients-with-essential-tremor/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/low-frequency-repetitive-transcranial-cerebellar-magnetic-stimulation-as-an-add-on-therapy-in-patients-with-essential-tremor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley